Gene · 7155
Papers2,315
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,315
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Refining the Role of Epigenetic Age Acceleration in Cardiotoxicity Research. | JACC CardioOncol | 2026 | 41705748 | PubTator, text mining | PubMed |
| predicTox: an integrated database of clinical risk frequencies and human gene expression signatures for cardiotoxic drugs. | Database (Oxford) | 2026 | 41627811 | PubTator, text mining | PubMed |
| Machine Learning-Based Integrative Analysis Identifies SUMOylation-Related Genes Underlying the Immune Heterogeneity of Sepsis. | IET Syst Biol | 2026 | 41616376 | PubTator, text mining | PubMed |
| Deciphering RNA and protein expression discordance identifies TOP2A as a prognostic biomarker and potential therapeutic target in lung adenocarcinoma. | Discov Oncol | 2026 | 41604018 | PubTator, text mining | PubMed |
| ICG-001 Provides Cardioprotection Against Doxorubicin-Induced Cardiotoxicity and Enhances Cancer Cytotoxicity. | JACC Basic Transl Sci | 2026 | 41579853 | PubTator, text mining | PubMed |
| In-silico identification of a Doxorubicin alternative with reduced cardiotoxicity informed by LLM-assisted modeling. | J Mol Graph Model | 2026 | 41223606 | PubTator, text mining | PubMed |
| Synthesis and evaluation of 1,2,3-triazole for selective Pb(II) detection and cytotoxic effect on HepG2 Cancer cells. | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 41172724 | PubTator, text mining | PubMed |
| DNA Topoisomerase II Mutations in Cancer: Structural Impact and Drug Response in High-grade Serous Ovarian Carcinoma. | J Mol Biol | 2026 | 40803551 | PubTator, text mining | PubMed |
| Across preclinical and clinical platforms, approved and investigational psychiatric drugs share pathways and associate with similar molecular functions. | Front Drug Discov (Lausanne) | 2025 | 42239657 | PubTator, text mining | PubMed |
| Chemotherapy-Induced Cardiotoxicity: Mechanisms, Detection and Emerging Therapies in Cardio-Oncology. | Discoveries (Craiova) | 2025 | 41583362 | PubTator, text mining | PubMed |
| TOP2B modulates DNA supercoiling and chromatin contacts during transcriptional induction. | Sci Adv | 2025 | 41296866 | PubTator, text mining | PubMed |
| Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomes. | Nat Commun | 2025 | 41271620 | PubTator, text mining | PubMed |
| Topoisomerase IIα orchestrates secretion of IL-6 and IL-8 with human papillomavirus replication. | Virol Sin | 2025 | 41271015 | PubTator, text mining | PubMed |
| Anthracyclines induce global changes in cardiomyocyte chromatin accessibility that overlap with cardiovascular disease loci. | PLoS Genet | 2025 | 41086241 | PubTator, text mining | PubMed |
| From bench to bedside: investigating SGLT2 inhibitors as a novel strategy against chemotherapy-induced cardiomyopathy. | Front Cardiovasc Med | 2025 | 41059442 | PubTator, text mining | PubMed |
| Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity. | Cells | 2025 | 41002436 | PubTator, text mining | PubMed |
| Coordinated control of genome-nuclear lamina interactions by topoisomerase 2B and lamin B receptor. | Nucleic Acids Res | 2025 | 41002030 | PubTator, text mining | PubMed |
| ATRX cooperates with TOP2B for replication fork stability and DNA damage response through G-quadruplex regulation. | Nucleic Acids Res | 2025 | 40990248 | PubTator, text mining | PubMed |
| Top2b regulates morphological and migratory properties of retinal progenitor cells in vivo and upon transplantable matrix substrates. | Explor Biomat X | 2025 | 40893167 | PubTator, text mining | PubMed |
| Ciprofloxacin enhances RSL3-induced ferroptosis by promoting mitochondrial Zn2+ accumulation via the STING1-CAV2 pathway. | J Biol Chem | 2025 | 40889676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7155/papers?page=3